Illustration for: Holtec Nuclear Targets $10.2B Valuation In IPO

Holtec Nuclear Targets $10.2B Valuation In IPO

Holtec Nuclear priced a $15-$18 range for its Nasdaq IPO, seeking up to $900 million and a valuation as high as $10.2 billion, as the SMR and spent-fuel company rides the same power crunch driving AI data-center demand.

By the Numbers

50M
Shares offered
$15-$18
Price range
up to $900M
Target proceeds
$8.5B-$10.2B
Valuation range
HNUC, Nasdaq
Ticker
TC
By the IPO Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
2 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

The diligence question for anyone tracking the SMR-financing wave: Holtec's decommissioning and spent-fuel revenue gives it a floor NuScale and Oklo don't have, but the market will price the SMR pipeline, not the legacy business -- so watch whether the stock trades on Palisades regulatory news or on quarterly decommissioning revenue, because that tells you which story investors actually bought.

Analysis

Holtec Nuclear launched its IPO roadshow with a price range of $15 to $18 per share, offering 50 million shares to raise up to $900 million at a valuation of as much as $10.2 billion, Reuters reported. Yahoo Finance confirmed the same range and a target listing around September 18. The company will list on Nasdaq under the ticker HNUC, with joint lead book-runners J.P. Morgan, Guggenheim Securities, Goldman Sachs, Citigroup, and BofA Securities.

A 40-Year-Old Company Riding A New Boom

Holtec was founded in 1986 by Krishna Singh and has spent most of its history in less glamorous corners of the nuclear industry: heat-transfer components, spent-fuel dry-cask storage, and decommissioning services for retired reactors. What's changed is the demand backdrop. Holtec is developing small modular reactors it plans to deploy first at its Palisades site in Michigan, where it's simultaneously working to restart the decommissioned 800-megawatt Palisades plant -- which would be the first US commercial reactor to resume operations after fully ceasing generation, a milestone with no precedent in US nuclear-regulatory history.

## Why Now, And Why It's Not Really About Reactors Holtec's IPO timing is inseparable from 2026's AI-driven power crunch.

Why Now, And Why It's Not Really About Reactors

Holtec's IPO timing is inseparable from 2026's AI-driven power crunch. Pulse has covered how hyperscalers are now signing decades-long nuclear power-purchase agreements -- Google's newly announced 20-year deal for half the output of Finland's Loviisa plant among the most recent examples -- because data-center electricity demand has outpaced what new gas or renewable capacity can supply on the timelines AI companies need. Holtec's SMR pipeline and its Palisades restart both sit squarely inside that same demand shock: a public listing lets the company raise growth capital against a genuinely improved market backdrop rather than the decades of flat-to-declining nuclear investment that preceded it.

The Competitive And Regulatory Picture

Holtec isn't alone in chasing SMR-driven capital. NuScale Power, X-energy, and Oklo have all raised public or growth capital this cycle on similar small-modular-reactor theses, though none combines Holtec's existing decommissioning and spent-fuel storage revenue base with a forward SMR pipeline the way this IPO does -- giving Holtec a revenue floor its earlier-stage SMR-pure-play peers don't have. The Palisades restart remains subject to Nuclear Regulatory Commission approval and has already faced delays relative to Holtec's original timeline; a restart of this scale and precedent-setting nature is unlikely to move faster than regulators are comfortable moving, IPO calendar notwithstanding.

What The Valuation Assumes

An $8.5-10.2 billion range for a company built substantially on decommissioning and storage services, with SMR deployment still years from generating meaningful revenue, is a bet that public investors will pay a growth multiple for nuclear-adjacent exposure to AI power demand even before the SMR business itself is proven commercially. That's a reasonable bet given the demand backdrop, but it's worth remembering that Holtec's SMR timeline, like every other SMR developer's, has already slipped once, and first-of-a-kind reactor projects have a long history of taking longer and costing more than initial estimates.

Where HNUC actually prices within its $15-$18 range around September 17-18 will say more about how the market splits Holtec's story than any single disclosure: a print near $18 says investors are buying the SMR narrative, a print near $15 says they're still valuing this as a decommissioning company that also does reactors.

ShareXLinkedInEmail

Key Sources

3 sources

Reported by Reuters · First reported by Yahoo Finance · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.